What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to disclose significant revisions to the employment agreements of CME Group's CEO, Phupinder S. Gill, and Executive Chairman & President, Terrence A. Duffy. These revisions impact their compensation, benefits, and severance packages.

How will the compensation of Terrence A. Duffy and Phupinder S. Gill change?

Both executives will see an increase in their minimum annual base salaries. Effective January 1, 2016, Mr. Duffy's base salary will increase to $1,500,000, and Mr. Gill's will increase to $1,250,000. Additionally, their target bonus opportunities and equity award opportunities will increase as a percentage of their base salaries, commencing January 1, 2016.

What are the implications of a 'termination without cause' under these new agreements?

In the event of a termination without cause, both Mr. Duffy and Mr. Gill are entitled to a lump sum severance payment equal to two times their then-current base salary, along with accrued benefits. Furthermore, outstanding unvested time-vesting equity awards will automatically vest, and performance-based equity awards will be assessed based on actual performance over the full term.

How do the new agreements address 'change of control' scenarios?

In the event of a change of control, all unvested time-vesting equity awards will become vested, and performance-based equity awards will be vested or forfeited based on actual performance over the full term, unless more favorable terms apply. Special provisions are also in place if an executive is terminated without cause within 60 days prior to a change of control.

CME 8-K: Leadership Changes

Summary

This Form 8-K filing by CME Group Inc. (CME) on November 11, 2015, details significant revisions to the employment agreements for two key executives: Terrence A. Duffy (Executive Chairman & President) and Phupinder S. Gill (Chief Executive Officer). These revised agreements, effective November 11, 2015, outline updated compensation structures, including base salaries, bonus targets, and equity incentives, reflecting changes from their previous agreements dated February 5, 2014. The updated agreements also specify terms for severance payments and equity vesting in various scenarios, such as termination without cause, change of control, death, or disability. These provisions are designed to ensure continuity and incentivize long-term performance and retention of senior leadership. Investors should note the potential impact of these executive compensation changes on the company's operating expenses and the alignment of executive interests with shareholder value.

Key Highlights

1Revised employment agreements for CEO Phupinder S. Gill and Executive Chairman & President Terrence A. Duffy, effective November 11, 2015.
2Increased minimum annual base salaries for both executives, with further increases effective January 1, 2016.
3Enhanced target bonus and equity award opportunities for both executives, tied to a percentage of their base salary.
4Revised severance packages, including a lump sum payment equal to two times current base salary in case of termination without cause.
5Updated provisions for accelerated vesting of equity awards upon termination without cause, change of control, death, or disability.
6Inclusion of non-compete clauses for both executives for one year following employment termination.
7Specific equity vesting triggers tied to future employment dates or expiration of agreement terms.

CME GROUP INC. 8-K Report, Executive Changes (Nov 12, 2015)

Summary

Key Highlights

Frequently Asked Questions